A recent study reveals that individuals who come off new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise plans.
Findings released in a prominent health publication points out that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"People buying these medications should be cognizant of the risk of quick weight regain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight in about a year and a half.
Analyzing Approaches
The analysis, which examined 37 of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with older methods.
The team note that individuals who shed pounds through lifestyle changes alone generally experience a slower weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Experts propose the mechanism of the jabs accounts for the heightened rebound.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement results in hunger is unsuppressed, making overeating far more likely."
A Chronic Disease?
The NHS suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, given the significant potential of relapse, the therapy is often long-term.
This view is echoed by drug manufacturers, who state that the results "highlight the chronic nature of obesity," similar to managing diseases like high blood pressure.
User Accounts
People who have discontinued the jabs explain a powerful resurgence of cravings.
"It felt as if something activating and you're instantly ravenous," recalled one woman.
The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during treatment.
Significant Adoption
Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a permanent solution and lasting health benefits relies on integrated lifestyle management.
